289 related articles for article (PubMed ID: 33160841)
1. Regulation of Normal and Malignant Hematopoiesis by FBOX Ubiquitin E3 Ligases.
Hynes-Smith RW; Wittorf KJ; Buckley SM
Trends Immunol; 2020 Dec; 41(12):1128-1140. PubMed ID: 33160841
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis.
Wittorf KJ; Weber KK; Swenson SA; Buckley SM
Exp Hematol; 2022 Oct; 114():33-42.e3. PubMed ID: 35987460
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin proteasome system in immune regulation and therapeutics.
Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
[TBL] [Abstract][Full Text] [Related]
4. Role of F-box E3-ubiquitin ligases in plant development and stress responses.
Saxena H; Negi H; Sharma B
Plant Cell Rep; 2023 Jul; 42(7):1133-1146. PubMed ID: 37195503
[TBL] [Abstract][Full Text] [Related]
5. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
6. New insights on the function of SCF ubiquitin E3 ligases in the lung.
Weathington NM; Mallampalli RK
Cell Signal; 2013 Sep; 25(9):1792-8. PubMed ID: 23680451
[TBL] [Abstract][Full Text] [Related]
7. Assaying proteasomal degradation in a cell-free system in plants.
García-Cano E; Zaltsman A; Citovsky V
J Vis Exp; 2014 Mar; (85):. PubMed ID: 24747194
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis.
Heuzé ML; Lamsoul I; Moog-Lutz C; Lutz PG
Blood Cells Mol Dis; 2008; 40(2):200-10. PubMed ID: 17919948
[TBL] [Abstract][Full Text] [Related]
9. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
[TBL] [Abstract][Full Text] [Related]
10. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin E3 Ligase FBXO9 Regulates Pluripotency by Targeting DPPA5 for Ubiquitylation and Degradation.
Swenson SA; Dobish KK; Peters HC; Bea Winship C; Willow Hynes-Smith R; Caplan M; Wittorf KJ; Ghosal G; Buckley SM
Stem Cells; 2024 Apr; 42(4):317-328. PubMed ID: 38227647
[TBL] [Abstract][Full Text] [Related]
12. Perilous journey: a tour of the ubiquitin-proteasome system.
Kleiger G; Mayor T
Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024
[TBL] [Abstract][Full Text] [Related]
13. Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system.
Buckley SM; Aranda-Orgilles B; Strikoudis A; Apostolou E; Loizou E; Moran-Crusio K; Farnsworth CL; Koller AA; Dasgupta R; Silva JC; Stadtfeld M; Hochedlinger K; Chen EI; Aifantis I
Cell Stem Cell; 2012 Dec; 11(6):783-98. PubMed ID: 23103054
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
Marteijn JA; Jansen JH; van der Reijden BA
Leukemia; 2006 Sep; 20(9):1511-8. PubMed ID: 16926849
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase on the biological properties of hematopoietic stem cell.
Zhan Q; Wang J; Zhang H; Zhang L
J Mol Med (Berl); 2023 May; 101(5):543-556. PubMed ID: 37081103
[TBL] [Abstract][Full Text] [Related]
16. Role of ubiquitin ligases in neural stem and progenitor cells.
Naujokat C
Arch Immunol Ther Exp (Warsz); 2009; 57(3):177-88. PubMed ID: 19479207
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulation by protein degradation.
Koepp DM
Methods Mol Biol; 2014; 1170():61-73. PubMed ID: 24906309
[TBL] [Abstract][Full Text] [Related]
18. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
Kitagawa K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
[TBL] [Abstract][Full Text] [Related]
19. Systematic approaches to identify E3 ligase substrates.
Iconomou M; Saunders DN
Biochem J; 2016 Nov; 473(22):4083-4101. PubMed ID: 27834739
[TBL] [Abstract][Full Text] [Related]
20. Roles of the ubiquitin-proteosome system in neurogenesis.
Tuoc TC; Stoykova A
Cell Cycle; 2010 Aug; 9(16):3174-80. PubMed ID: 20852390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
